The amount of clout this brings is worth more than the 2.1 million they're bringing to the table.
Outlook is very positive "CY21 Annualised Monthly Revenue by December 2021 is likely to be at the higher end of our forecast range of US$110-120million. The company will continue its strategy to further invest resources on growth opportunities as they emerge, and the current momentum provides confidence to accelerate these initiatives further."
- Forums
- ASX - By Stock
- 360
- Ann: Market Update
Ann: Market Update, page-3
Featured News
Add 360 (ASX) to my watchlist
(20min delay)
|
|||||
Last
$21.22 |
Change
-1.530(6.73%) |
Mkt cap ! $3.900B |
Open | High | Low | Value | Volume |
$21.53 | $21.65 | $20.82 | $63.25M | 2.970M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 2974 | $21.21 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$21.22 | 3133 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 2974 | 21.210 |
2 | 671 | 21.200 |
1 | 466 | 21.190 |
1 | 1000 | 21.180 |
2 | 5080 | 21.170 |
Price($) | Vol. | No. |
---|---|---|
21.220 | 3133 | 1 |
21.230 | 1248 | 1 |
21.240 | 3074 | 1 |
21.260 | 4024 | 2 |
21.270 | 1892 | 1 |
Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
Featured News
360 (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online